Featured Opinions
The Opportunity for Women’s Health in Emerging Markets
by Marc Yates
Challenging awareness, attitudes and access barriers.
Why have patients become angrier despite the rise in patient centricity?
by Kevin Dolgin
Do the KPIs on pharma's dashboard include adherence, a key indicator of patient centricity and is it time for a standard measure?
Pharma Should Not Try to Build a Patient-Centric Image
by Jill Donahue
Patient centricity needs to live in our people, not just our projects, our actions, not just our words.
Victoria Williams, VP & Sales Director at GSK urges women to put themselves forward and avoid over-questioning their capabilities.
Planning for Success in an IDN Environment
Manufacturers can be a valuable partner helping IDNs create a more compelling economic & clinical value case to external constituencies.
We sent Tina Boggiano to CES in Las Vegas to find out what consumer electronics can deliver for digital health in pharma.
Digital Marketing: Time to Start Thinking Outside the Box
Is digital being used effectively by pharma?
Using Data-Driven Insights and Analytics to Drive Decision Making
How data-driven insights can be used to effectively drive decision making within price and access.
Taiwan: Exploring the Healthcare Opportunity in this Singular “Hybrid” Market
by Marc Yates
How large is the opportunity for pharma and healthcare companies in Taiwan?
Cross My Heart and Hope to Die; Better Patient Centricity Requires Better Patients
Cross my heart and hope to die should not be the promise brokered between healthy volunteers entering a clinical trial.
Spot the Opportunities Others Miss
To change the habit of the present, you need to trigger new ways of thinking that convey the attraction of the new solution.
Getting the Most Out of Pharma’s Digital Assets
How the “backward” nature of digital assets requires a different approach to that of drug assets.
6 Tips to Avoid the Jan 17 "Dump your Resolutions Day" Blues
by Jill Donahue
How to make those resolutions stick.
For Natalie Woodford, getting her job right will be the difference between GSK succeeding or failing in its mission.
by Jeff Elton
The focus on value implies a focus that is broader than the therapeutic alone.
Innovation from Disruptive Global Change
Leaders need to constantly shape the culture of the organization so that it evolves and is relevant.
What to Consider When Conducting Patient Research in Saudi Arabia
by Marc Yates
The need to understand the patient as a key stakeholder is now recognized by pharma across the globe.
by David Laws
I vividly recall when I first joined the industry and my first day out with a rep ‘on territory’. What an eye opener that was for me.
Predictions for 2016 - Pharma and Beyond
As 2015 draws close to an end, we begin to reflect upon where we are now and consider where we're headed.
Melinda Richter, JLABS on how helping to empower genius will liberate science and improve patient outcomes.
Go Hack Yourself; The Year that Data got Personal
The unrelenting charge by patients to be "health hackers". How will pharma respond?
Adaptability: Using Change for Competitive Advantage
The PR & MA environment is evolving at a fast pace and securing access at the right price remains challenging.